Our test repertoire includes standard of care and more comprehensive molecular profiling to identify a deeper understanding of individual tumours and potential clinical trials.
EGFR, KRAS, BRAF, MET, ERBB2 (Can be combined with MBS rebatable PDL1, ALK and ROS1 IHC/FISH)
Covered by MBS items:
- 73337 – EGFR
- 73436 - MET exon 14 skipping
If no variants are detected, RNA is tested to look for MET exon 14 skipping.
If no drivers are identified by NGS then ROS1 IHC is performed.
ALK and ROS1 fusions are confirmed by FISH.
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
- IHC - fresh tissue or FFPE block/slides (15 x 5-micron sections on positively charged slides)
TAT: 1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
EGFR – DNA only
Fully covered (MBS item 73337)
$337.75 (non-MBS eligible)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
TAT: <1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
Fully covered (MBS item 73436)
$337.75 (non-MBS eligible)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
TAT: 1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
DNA only testing
Sample taken after progression on EGFR TKI is required.
Fully covered (MBS item 73351)
$337.75 (non-MBS eligible)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
TAT: <1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific) or digital droplet PCR (ddPCR)
BRAF, NRAS, KIT, GNAQ, GNA11
Fully covered (MBS item 73336)
$196.35 (non-MBS eligible)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
TAT: <1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
KRAS, NRAS, BRAF, PIK3CA
Fully covered (MBS item 73338)
$308.25 (non-MBS eligible)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
TAT: <1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
KIT, PDGFRA, BRAF
DNA only testing.
If no variants are found by NGS, SDHB and panTRK IHC are performed.
$350 (not MBS covered)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
- IHC - fresh tissue or FFPE block/slides (15 x 5-micron sections on positively charged slides)
TAT: 1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
PIK3CA
$350 (not MBS covered)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
TAT: <1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
BRAF, NRAS, KRAS, RET, HRAS.
$350 (not MBS covered).
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
TAT: 1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
BRAF, NRAS, KRAS, RET, HRAS plus RNA alterations
$885 (not MBS covered)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
TAT: 1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
$350 (not MBS covered)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
TAT: <1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
$350 (not MBS covered)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
TAT: <1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
Small DNA Variants - AKT1, AKT2, AKT3, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2, CTNNB1, EGFR, ERBB2, ERBB3, ERBB4, ESR1, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, GNA11, GNAQ, GNAS, HRAS, IDH1, IDH2, KIT, KRAS, MAP2K1, MAP2K2, MET, MTOR, NRAS, NTRK1, NTRK2, NTRK3, PDGFRA, PIK3CA, PTEN, RAF1, RET, ROS1, SMO, TP53.
CNA – ALK, AR, CD274, CDKN2A, EGFR, ERBB2, ERBB3, FGFR1, FGFR2, FGFR3, KRAS, MET, PIK3CA, PTEN.
Covers small DNA variants in targeted hotspot regions, and copy number alterations (CNAs) in selected genes.
$600 DNA (not MBS covered)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
TAT: 1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
RNA Fusions - ALK, BRAF, ESR1, FGFR1, FGFR2, FGFR3, MET, NRG1, NTRK1, NTRK2, NTRK3, NUTM1, RET, ROS1, RSPO2, RSPO3
Splice Variants – AR-V7, EGFRvIII, and MET exon 14 skipping variants
$600 RNA (not MBS covered)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
TAT: 1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
Small DNA Variants - AKT1, AKT2, AKT3, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2, CTNNB1, EGFR, ERBB2, ERBB3, ERBB4, ESR1, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, GNA11, GNAQ, GNAS, HRAS, IDH1, IDH2, KIT, KRAS, MAP2K1, MAP2K2, MET, MTOR, NRAS, NTRK1, NTRK2, NTRK3, PDGFRA, PIK3CA, PTEN, RAF1, RET, ROS1, SMO, TP53.
CNA – ALK, AR, CD274, CDKN2A, EGFR, ERBB2, ERBB3, FGFR1, FGFR2, FGFR3, KRAS, MET, PIK3CA, PTEN.
RNA Fusions - ALK, BRAF, ESR1, FGFR1, FGFR2, FGFR3, MET, NRG1, NTRK1, NTRK2, NTRK3, NUTM1, RET, ROS1, RSPO2, RSPO3
RNA Splice Variants – AR-V7, EGFRvIII, and MET exon 14 skipping variants
Covers small DNA variants in targeted hotspot regions, copy number alterations, fusions and splice variants in selected genes.
$885 RNA & DNA (not MBS covered)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
TAT: 1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
Small DNA Variants - AKT1, AKT2, AKT3, ALK, AR, ARAF, BRAF, CDK4, CDKN2A, CHEK2, CTNNB1, EGFR, ERBB2, ERBB3, ERBB4, ESR1, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, GNA11, GNAQ, GNAS, HRAS, IDH1, IDH2, KIT, KRAS, MAP2K1, MAP2K2, MET, MTOR, NRAS, NTRK1, NTRK2, NTRK3, PDGFRA, PIK3CA, PTEN, RAF1, RET, ROS1, SMO, TP53.
CNA – ALK, AR, CD274, CDKN2A, EGFR, ERBB2, ERBB3, FGFR1, FGFR2, FGFR3, KRAS, MET, PIK3CA, PTEN.
$350 per gene (not MBS covered)
TAT: 1 Week (from specimen receipt)
Methodology: Oncomine Precision Assay (ThermoFisher Scientific)
Fully covered (MBS item 73377)
$212.50 (non-MBS eligible)
Preferred samples:
fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
- TAT: 2 Weeks (from specimen receipt)
Methodology: Sanger sequencing looking for the c.402C>G p.(C134W) variant.
Comprehensive genomic profiling for solid tumours including small sequence variants (523 genes), gene amplifications, gene fusions (55 genes), tumour mutation burden (TMB) and microsatellite instability (MSI). Contact mol path for further information.
$2,500 (not MBS covered)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
TAT: ~3 Weeks (from specimen receipt)
BRCA1, BRCA2
$600 (non-MBS eligible)
Fully covered (MBS item 73303 - prostate)
Fully covered (MBS item 73301 - ovarian)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
Methodology: NGS (QIAseq)
$200 (not MBS covered)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
Methodology: Methylation Specific MLPA (MS-MLPA) & fragment analysis
$300 (not MBS {slider=Accordion title}covered)
Preferred samples:
- fresh tissue or FFPE block/slides (10 x 5-micron sections on positively charged slides)
Methodology: Methylation Specific MLPA (MS-MLPA) & fragment analysis
ctDNA testing
$475 (not MBS eligible)
*The V600E assay does not detect the DNA change c.1799_1800delinsAA, which also results in p.Val600Glu (V600E) also referred to as V600E2.
TAT: 3 Business days
Methodology: Digital droplet PCR (ddPCR)
$475 (not MBS eligible)
TAT: 3 Business days
Methodology: Digital droplet PCR (ddPCR)
$525 (not MBS eligible)
*The V600E assay does not detect the DNA change c.1799_1800delinsAA, which also results in p.Val600Glu (V600E) also referred to as V600E2.
TAT: 3 Business days
Methodology: Digital droplet PCR (ddPCR)
$475 (not MBS eligible)
TAT: 3 Business days
Methodology: Digital droplet PCR (ddPCR)
$525 (not MBS eligible)
EGFR activating variants available for testing:
- c.2573T>G p.(Leu858Arg)
- c.2156G>C p.(Gly719Ala)
- c.2582T>A p.(Leu861Gln)
- c.2235_2249del p.(Glu746_Ala750del)
- c.2236_2250del p.(Glu746_Ala750del)
TAT: 3 Business days
Methodology: Digital droplet PCR (ddPCR)
$475 (not MBS eligible)
TAT: 3 Business days
Methodology: Digital droplet PCR (ddPCR)
$475 (not MBS eligible)
TAT: 3 Business days
Methodology: Digital droplet PCR (ddPCR)
$475 (not MBS eligible)
TAT: 3 Business days
Methodology: Digital droplet PCR (ddPCR)
$475 (not MBS eligible)
TAT: 3 Business days
Methodology: Digital droplet PCR (ddPCR)
$725 (not MBS eligible)
TAT: 3 Business days
Methodology: Digital droplet PCR (ddPCR)
Next generation sequencing (NGS) liquid biopsy assay which includes analysis of small DNA sequence variants, selected gene fusions and gene amplifications (not clinically validated) in 77 genes. Contact mol path for further information.
$3,500 (not MBS eligible)
TAT: ~3 Weeks
Sample requirements:
Whole blood collected into 2x 10 mL Streck tubes. Note: collection technique impacts quality of test result, please contact mol path for further information.
Molecular Oncology contact
- Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
- Phone: (03) 8559 5405
- Fax: (03) 8559 5437
Go back to the Molecular Pathology page